FMS (Fresenius Medical Care AG) Retained Earnings: $14,222 Mil (As of Mar. 2026)


FMS Fresenius Medical Care AG FMS
72 GF Score
Price $23.53
GF Value $23.57
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG Retained Earnings?

Fresenius Medical Care AG FMS +2.93% 72 Retained Earnings is $14,222 Mil as of Mar. 2026. GuruFocus rates FMS with a GF Score™ of 72/100 and a GF Value™ of $23.57 (Fairly Valued). The stock has 4 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Fresenius Medical Care AG's retained earnings for the quarter that ended in Mar. 2026 was $14,222 Mil.

Fresenius Medical Care AG's quarterly retained earnings increased from Sep. 2025 ($13,902 Mil) to Dec. 2025 ($14,295 Mil) but then declined from Dec. 2025 ($14,295 Mil) to Mar. 2026 ($14,222 Mil).

Fresenius Medical Care AG's annual retained earnings declined from Dec. 2023 ($11,910 Mil) to Dec. 2024 ($11,797 Mil) but then increased from Dec. 2024 ($11,797 Mil) to Dec. 2025 ($14,295 Mil).


Fresenius Medical Care AG  (NYSE:FMS) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Fresenius Medical Care AG Retained Earnings Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG Retained Earnings Chart

Fresenius Medical Care AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,232.93 11,347.15 11,910.24 11,797.16 14,294.98

Fresenius Medical Care AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,403.69 13,025.81 13,902.10 14,294.98 14,221.52
FMS
72GF Score
Fresenius Medical Care AG FMS
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius Medical Care AG Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $14,222 Mil mean?
Fresenius Medical Care AG (FMS) has a Retained Earnings of $14,222 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Fresenius Medical Care AG and its competitors.
Is Fresenius Medical Care AG's Retained Earnings too high?
Fresenius Medical Care AG's current Retained Earnings is $14,222 Mil. Overall, Fresenius Medical Care AG has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Retained Earnings compare to HCA and THC?
Fresenius Medical Care AG's Retained Earnings of $14,222 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Healthcare Providers & Services company?
A good Retained Earnings depends on the Healthcare Providers & Services industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Fresenius Medical Care AG and its competitors. Fresenius Medical Care AG's current Retained Earnings is $14,222 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (FMS) is currently considered Fairly Valued. The stock's GF Value™ is $23.57, compared to a current price of $23.53 — trading 0.2% below its estimated fair value. The current Retained Earnings is $14,222 Mil. Fresenius Medical Care AG's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Fresenius Medical Care AG (FMS), the current Retained Earnings is $14,222 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (FMS) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of $23.53 is trading 0.2% below its estimated GF Value™ of $23.57. GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.

Key valuation signals for FMS:

  • Retained Earnings: $14,222 Mil
  • GF Value™: $23.57 vs. price of $23.53 (0.2% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the FMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
72GF Score

Get the complete analysis for FMS

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.53
Price
$23.57
GF Value